// App-Quantinova.ai

EPCO-47 : ITCC-P4: GENOMIC PROFILING AND ANALYSES OF PEDIATRIC PATIENT TUMOR AND PATIENT-DERIVED XENOGRAFT (PDX) MODELS FOR HIGH THROUGHPUT IN VIVO TESTING

Researchers

Presenter

  • Apurva Gopisetty

Principal Investigators

  • Didier Surdez

  • Elnaz Saberi-Ansari

  • Yasmine Iddir

  • Alexandra Saint-Charles

  • Joshua Waterfall

  • Justyna Wierzbinska

  • Andreas Schlicker

  • Norman Mack

  • Benjamin Schwalm

  • David T Jones

  • Johannes Gojo

  • Louis Chesler

  • Gilles Vassal

  • Lou Stancato

  • Jan Koster

  • Jan J Molenaar

  • Natalie Jaeger

  • Gudrun Schleiermacher

  • Stefan Pfister

  • Marcel Kool

Medical Centers

  • INSERM U830, Équipe Labellisée LNCC, Genetics and Biology of Pediatric Cancers, PSL Research University, SIREDO Oncology Centre, Institut Curie Research Centre, Paris, France, Paris, France

  • Eli Lilly and Company, Indianapolis, IN, USA

  • Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands, Utrecht, Netherlands

  • German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany, Heidelberg, Baden-Wurttemberg, Germany

  • Medical University of Vienna, Vienna, Austria

  • Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom, London, United Kingdom

  • Department of Clinical Research, Gustave Roussy, Villejuif, France, Paris, France

  • Hopp Childrens Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ), Heidelberg, Germany

  • Bayer AG, Pharmaceuticals, Research and Development, Berlin, Germany, Berlin, Germany

  • Department of Oncogenomics, Amsterdam University Medical Centre, Amsterdam, the Netherlands, Amsterdam, Netherlands

Locations

  • France

  • United Kingdom

  • United States

  • Netherlands

  • Germany

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • High-Grade Gliomas

  • Brain cancer

  • Gliomas

  • Solid malignancies

Biomarkers

  • MYCN proto-oncogene, bHLH transcription factor

  • MYB proto-oncogene, transcription factor

  • Phosphatase and tensin homolog

  • cMYC

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved